Ehave Signs Licensing Agreement To Enhance Its Telemedicine Platform

Ehave, Inc., , A Provider Of Digital Therapeutics Delivering Evidence-Based Therapeutic Interventions To Patients, Announced It Is Entering Into A Licensing Agreement With A Telemedicine Solutions Provider From A Single Integrated Platform. Under The Terms Of The Agreement Ehave Will Provide Its Patients Access To The Telemedicine Solutions Provider&Rsquo;S Complete Suite Of Single Integrated Platform. This Online Platform Offers A Complete Suite Of Telemedicine Solutions Allowing Members To Request An Online Consultation, To Obtain A Second Medical Opinion In As Fast As 48 Hours Or Access Their Complete Medical History Anytime, Anywhere From Their Computer Or Mobile Device. Members Will Be Able To Share Their Medical History With Select Family Members And Providers To Improve Treatment Outcomes And Cultivate Better Care, Helping To Save, Money, Time And Lives.Separately, Ehave, Inc. Has Recently Finalized An Agreement With Burst Iq For 1 Tb Of Transactions On The Blockchain Per Month. Ehave Plans To Work With Burst Iq To Develop Video Surveys With Analysis For Both Covid-19 And People Taking Psychedelics. The Questions Are Onscreen And Allow The Participant To Answer Them As They Go Through The Video.Ehave Is Also Expecting The Hospital For Sick Children In Toronto (&Ldquo;Sickkids&Rdquo;) To Start Up Its Trials For Megateam Assessment And Rehabilitation Products After Covid-19. Shareholders And Other Interested Parties Can Read More At Https://Www.Ehave.Com/Adhd-Pilot-Program.Ehave, Inc. Ceo Ben Kaplan Said, &Ldquo;As We Move Toward The Psychedelic Space, We Are Looking To Advance The Ways Individuals Can Control Their Medical History. We Expect To Release More Information Regarding Our Longer Term Plans At A Later Time.&Rdquo;

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!